Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey F Waring

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Current Protocols in Pharmacology|September 30, 2011
Overview of microarrays in drug discovery and developmentJeffrey F Waring
Current Opinion in Drug Discovery & Development|February 1, 2005
Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compoundsJeffrey F Waring, Mark G Anderson
Current Opinion in Molecular Therapeutics|July 26, 2002
The promise of toxicogenomicsJeffrey F Waring, Donald N Halbert
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
Investigations toward enhanced understanding of hepatic idiosyncratic drug reactionsMichael J Liguori, Jeffrey F Waring
Biomarkers in Medicine|February 3, 2012
Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depressionHong I Wan, Holly Soares, Jeffrey F Waring
Chemico-Biological Interactions|November 4, 2004
Toxicogenomics in drug discovery: from preclinical studies to clinical trialsYi Yang, Eric A G Blomme, Jeffrey F Waring
Journal of Neurochemistry|May 20, 2008
Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cellsMin Hu, Jeffrey F Waring, Murali Gopalakrishnan, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 2, 2008
Use of traditional end points and gene dysregulation to understand mechanisms of toxicity: toxicogenomics in mechanistic toxicologyWayne R Buck, Jeffrey F Waring, Eric A Blomme
Toxicology Letters|November 11, 2008
Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and developmentEric A G Blomme, Yi Yang, Jeffrey F Waring
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 31, 2007
Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cellsMichael J Liguori, Eric A G Blomme, Jeffrey F Waring
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Current Protocols in Pharmacology|September 30, 2011
Overview of microarrays in drug discovery and developmentJeffrey F Waring
Current Opinion in Drug Discovery & Development|February 1, 2005
Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compoundsJeffrey F Waring, Mark G Anderson
Current Opinion in Molecular Therapeutics|July 26, 2002
The promise of toxicogenomicsJeffrey F Waring, Donald N Halbert
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
Investigations toward enhanced understanding of hepatic idiosyncratic drug reactionsMichael J Liguori, Jeffrey F Waring
Biomarkers in Medicine|February 3, 2012
Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depressionHong I Wan, Holly Soares, Jeffrey F Waring
Chemico-Biological Interactions|November 4, 2004
Toxicogenomics in drug discovery: from preclinical studies to clinical trialsYi Yang, Eric A G Blomme, Jeffrey F Waring
Journal of Neurochemistry|May 20, 2008
Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cellsMin Hu, Jeffrey F Waring, Murali Gopalakrishnan, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 2, 2008
Use of traditional end points and gene dysregulation to understand mechanisms of toxicity: toxicogenomics in mechanistic toxicologyWayne R Buck, Jeffrey F Waring, Eric A Blomme
Toxicology Letters|November 11, 2008
Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and developmentEric A G Blomme, Yi Yang, Jeffrey F Waring
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 31, 2007
Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cellsMichael J Liguori, Eric A G Blomme, Jeffrey F Waring
Pageof 7